SCHEMBL7155169

SCHEMBL7155169

CC(=O)Nc1ccc(C(=O)O)c(OC(C)=O)c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.61
HSD17B10 Q99714 3/20 0.55
ALDH1A1 P00352 3/20 0.55
HPGD P15428 2/20 0.55
CYP2C19 P33261 2/20 0.55
USP2 O75604 1/20 0.55
TDP1 Q9NUW8 2/20 0.53
ESR1 P03372 1/20 0.53
ITGB3 P05106 1/20 0.53
ITGA2B P08514 1/20 0.53
HMGB1 P09429 1/20 0.53
TSHR P16473 1/20 0.53
GGT1 P19440 1/20 0.53
PTGS1 P23219 1/20 0.53
PTGS2 P35354 1/20 0.53
BLM P54132 1/20 0.53
NAPRT Q6XQN6 1/20 0.53
CFD P00746 2/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
MYC P01106 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10334083 0.87 CFD (0.63) KDM4EHSD17B10ALDH1A1HPGDTDP1
SCHEMBL7411536 0.86 TDP1 (0.69) KDM4EHSD17B10ALDH1A1HPGDCYP2C19
SCHEMBL1162352 0.85 TDP1 (0.56) KDM4EALDH1A1HPGDCYP2C19TDP1
SCHEMBL2350573 0.85 KDM4E (0.55) KDM4EHSD17B10ALDH1A1HPGDCYP2C19
SCHEMBL2351442 0.84 KDM4E (0.54) KDM4EHSD17B10ALDH1A1HPGDCYP2C19
SCHEMBL7199385 0.83 HSD17B10 (0.56) KDM4EHSD17B10ALDH1A1HPGDCYP2C19
SCHEMBL25063116 0.83 KDM4E (0.52) KDM4EHSD17B10ALDH1A1HPGDCYP2C19
SCHEMBL24072456 0.83 KDM4E (0.52) KDM4EHSD17B10ALDH1A1HPGDCYP2C19
SCHEMBL28493212 0.81 RORC (0.62) KDM4EALDH1A1TDP1SMN1; SMN2MYC
SCHEMBL7371976 0.81 TDP1 (0.76) KDM4EHSD17B10ALDH1A1TDP1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5985927-A Medicaments for the selective treatment of tumor tissues KREUTZ WERNER (DE) 1999-11-16 US claimed
EP-0817623-B1 MEDICAMENTS FOR THE SELECTIVE TREATMENT OF TUMOUR TISSUES KREUTZ WERNER PROF DR (DE) 2003-11-12 EP disclosed
US-5985927-A Medicaments for the selective treatment of tumor tissues KREUTZ WERNER (DE) 1999-11-16 US disclosed
US-4933330-A PSORIASIS DAK-LABORATORIET (DK) 1990-06-12 US disclosed
EP-0291159-A2 Aminosalicylic-acid derivatives for the treatment of psoriasis DAK-LABORATORIET A/S (DK) 1988-11-17 EP disclosed
US-4267174-A AND PROCESS FOR ADMINISTERING BOEHRINGER MANNHEIM, GMBH (DE) 1981-05-12 US disclosed
US-4006239-A Benzoic acid amides for mycobacterium infections BAYER AKTIENGESELLSCHAFT (DT) 1977-02-01 US disclosed